EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles

Silvia Mutti iD, Alessia Cavalleri iD, Stefania Federici, Valentina Mangolini, Lucia Paolini iD, Cristian Bonvicini iD, Rosalba Monica Ferraro, Elena Laura Mazzoldi, Luca Garuffo, Besjana Xhahysa, Alessandro Leoni, Federica Trenta und 7 weitere

Journal of Cellular and Molecular Medicine · 2025-10 · 29 (20)

DOI: 10.1111/jcmm.70901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.10.2025. Verfasst von Silvia Mutti und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Diseases and Bone Marrow Transplant, ASST Spedali Civili, Bres…. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Extracellular Vesicles, Models, Biological. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic Myeloid Leukaemia is driven by the BCR::ABL1 fusion gene. Although Tyrosine Kinase Inhibitors have significantly improved patient outcomes, drug resistance and disease persistence remain challenges, highlighting the need for effective preclinical models. We observed cellular heterogeneity among CML models in response to TKIs, influencing viability, metabolism, and molecular markers. With growing interest in extracellular vesicles as mediators of leukaemia progression via oncogenic cargo like BCR::ABL1, we explored whether EVs from different CML cell lines exhibit distinct features. EVs from K562 and KCL22 cells were characterised under basal conditions using Fourier Transform Infrared spectroscopy, Atomic Force Microscopy, dot blotting, and Nanoparticle Tracking Analysis. We assessed EV release and BCR::ABL1 content before and after treatment with imatinib, nilotinib, or dasatinib, alongside Ki67 expression to gauge proliferation. Fourier Transform Infrared Spectroscopy with Principal Component Analysis revealed distinct clustering of EVs by cell line. While untreated K562 and KCL22 cells showed similar EV output and BCR::ABL1 content, post‐treatment K562 cells released more EVs with elevated BCR::ABL1 transcripts. KCL22 cells showed earlier reduction in Ki67 expression. These findings highlight model‐dependent EV behaviour, reflecting patient heterogeneity and reinforcing the need for careful model selection in CML research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracellular VesiclesModels, BiologicalHumansFusion Proteins, bcr-ablK562 CellsCell ProliferationProtein Kinase InhibitorsCell Line, TumorImatinib MesylateKi-67 Antigen

Stichwörter der Autor:innen

Fourier‐transform infrared spectroscopyK562KCL22chronic myeloid leukaemiaextracellular vesiclestyrosine kinase inhibitors

Substanzen

Fusion Proteins, bcr-ablProtein Kinase InhibitorsImatinib MesylateKi-67 Antigen

Autor:innen und Institutionen

  • Department of Clinical and Experimental Sciences, University of Brescia, Unit of Blood Diseases and Bone Marrow Transplant, ASST Spedali Civili, Brescia, Italy.
  • Centro di Ricerca Emato-Oncologica AIL (CREA), ASST Spedali Civili di Brescia, Brescia, Italy.
  • Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy.
  • National Interuniversity Consortium of Materials Science and Technology (INSTM), Florence, Italy.
  • Department of Molecular and Translational Medicine (DMMT), Università di Brescia, Brescia, Italy.
  • IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.

ORCID-Profile: Silvia Mutti, Alessia Cavalleri, Lucia Paolini, Cristian Bonvicini, Federica Re, Mirko Farina, Simona Bernardi

Zitieren

APA

Mutti, S., Cavalleri, A., Federici, S., Mangolini, V., Paolini, L., Bonvicini, C., Ferraro, R. M., Mazzoldi, E. L., Garuffo, L., Xhahysa, B., Leoni, A., Trenta, F., Re, F., Giliani, S. C., Avenoso, D., Farina, M., Malagola, M., Russo, D., & Bernardi, S. (2025). Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles. Journal of Cellular and Molecular Medicine, 29(20). https://doi.org/10.1111/jcmm.70901

Vancouver

Mutti S, Cavalleri A, Federici S, Mangolini V, Paolini L, Bonvicini C, et al. Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles. Journal of Cellular and Molecular Medicine. 2025;29(20). doi:10.1111/jcmm.70901

BibTeX
@article{Mutti2025,
  author = {Mutti, Silvia and Cavalleri, Alessia and Federici, Stefania and Mangolini, Valentina and Paolini, Lucia and Bonvicini, Cristian and Ferraro, Rosalba Monica and Mazzoldi, Elena Laura and Garuffo, Luca and Xhahysa, Besjana and Leoni, Alessandro and Trenta, Federica and Re, Federica and Giliani, Silvia Clara and Avenoso, Daniele and Farina, Mirko and Malagola, Michele and Russo, Domenico and Bernardi, Simona},
  title = {Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {20},
  doi = {10.1111/jcmm.70901}
}
Kostenlos starten →